{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:29:30Z","timestamp":1790882970660,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1007\/bf02737809","type":"journal-article","created":{"date-parts":[[2007,10,29]],"date-time":"2007-10-29T05:55:31Z","timestamp":1193637331000},"page":"135-160","source":"Crossref","is-referenced-by-count":28,"title":["Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes"],"prefix":"10.1007","volume":"28","author":[{"given":"Xin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Weltzien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02737809_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.184.4132.19","volume":"184","author":"H. R. Bourne","year":"1974","unstructured":"Bourne, H. R., Lichtenstein, L. M., Melmon, K. L., Henney, C. S., Weinstein, Y., and Shearer, G. M. (1974) Modulation of inflammation and immunity by cyclic AMP.Science 184, 19\u201328.","journal-title":"Science"},{"key":"BF02737809_CR2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0167-5699(88)91220-0","volume":"9","author":"G. M. Kammer","year":"1988","unstructured":"Kammer, G. M. (1988) The adenylate cyclase\u2014cAMP\u2014protein kinase A pathway and regulation of the immune response.Immunol. Today 9, 222\u2013229.","journal-title":"Immunol. Today"},{"key":"BF02737809_CR3","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1073\/pnas.83.15.5673","volume":"83","author":"J. B. Imboden","year":"1986","unstructured":"Imboden, J. B., Sloback, D. M., Patterson, G., and Stoba, S. D. (1986) Cholera toxin inhibits T cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium.Proc. Natl. Acad. Sci. USA 83, 5673\u20135677.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02737809_CR4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4049\/jimmunol.140.3.936","volume":"140","author":"A. Lerner","year":"1988","unstructured":"Lerner, A., Jacobson, B., and Mitler, R. A. (1988) Cyclic AMP concentrations modulate both calcium flux and hydrolysis of phosphatidylinositol phosphates in mouse T lymphocytes.J. Immunol. 140, 936\u2013940.","journal-title":"J. Immunol."},{"key":"BF02737809_CR5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj2840189","volume":"284","author":"M. A. Alava","year":"1992","unstructured":"Alava, M. A., DeBell, K. E., Conti, A., Hoffman, T., and Bonvini, E. (1992) Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor\/CD3 complex but not by G-protein stimulation.Biochem. J. 284, 189\u2013199.","journal-title":"Biochem. J."},{"key":"BF02737809_CR6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4049\/jimmunol.139.4.1179","volume":"139","author":"D. Mary","year":"1987","unstructured":"Mary, D., Aussel, C., Ferrua, B., and Fehlmann, M. (1987) Regulation of interleukin 2 synthesis by cAMP in human T cells.J. Immunol. 139, 1179\u20131184.","journal-title":"J. Immunol."},{"key":"BF02737809_CR7","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.4049\/jimmunol.145.8.2616","volume":"145","author":"R. Minakuchi","year":"1990","unstructured":"Minakuchi, R., Wacholtz, M. C., Davis, L. R., and Lipsky, P. E. (1990) Delineation of the mechanism of inhibition of human T cell activation by PGE2.J. Immunol. 145, 2616\u20132631.","journal-title":"J. Immunol."},{"key":"BF02737809_CR8","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.148.9.2845","volume":"148","author":"E. D. Anastassiou","year":"1992","unstructured":"Anastassiou, E. D., Paliogianni, F., Balow, J. P., Yamada, H., and Boumpas, D. T. (1992) Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R\u03b1 gene expression at multiple levels.J. Immunol. 148, 2845\u20132852.","journal-title":"J. Immunol."},{"key":"BF02737809_CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4049\/jimmunol.145.2.449","volume":"145","author":"D. S. Lingk","year":"1990","unstructured":"Lingk, D. S., Chan, M. A., and Gelfand, E. W. (1990) Increased cyclic adenosine monophosphate levels block progression but not initiation of human T cell proliferation.J. Immunol. 145, 449\u2013455.","journal-title":"J. Immunol."},{"key":"BF02737809_CR10","doi-asserted-by":"crossref","first-page":"18,094","DOI":"10.1074\/jbc.270.30.18094","volume":"270","author":"Y.-P. Hsueh","year":"1995","unstructured":"Hsueh, Y.-P., and Lai, M.-Z. (1995) C-jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes.J. Biol. Chem. 270, 18,094\u201318,098.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR11","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4049\/jimmunol.157.4.1514","volume":"157","author":"A. Tamir","year":"1996","unstructured":"Tamir, A., Granot, Y., and Isakov, N. (1996) Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-jun N-terminal kinase.J. Immunol. 157, 1514\u20131522.","journal-title":"J. Immunol."},{"key":"BF02737809_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1126\/science.208147","volume":"201","author":"T. Wang","year":"1978","unstructured":"Wang, T., Sheppard, J. R., and Foker, J. E. (1978) Rise and fall of cyclic AMP required for onset of lymphocyte DNA synthesis.Science 201, 155\u2013157.","journal-title":"Science"},{"key":"BF02737809_CR13","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.4049\/jimmunol.156.12.4582","volume":"156","author":"N. Feuerstein","year":"1996","unstructured":"Feuerstein, N., Firestein, R., Aiyar, N., He, X., Murasko, D., and Cristofalo, V. (1996) Late induction of CREB\/ATF binding and a concomitant increase in cAMP levels in T and B lymphocytes stimulated via the antigen receptor.J. Immunol. 156, 4582\u20134593.","journal-title":"J. Immunol."},{"key":"BF02737809_CR14","first-page":"721","volume":"77","author":"C. Rochette-Egly","year":"1981","unstructured":"Rochette-Egly, C. and Kempf, J. (1981) Cyclic nucleotides and calcium in human lymphocytes induced to divide.J. Physiol. (Paris)77, 721\u2013725.","journal-title":"J. Physiol. (Paris)"},{"key":"BF02737809_CR15","doi-asserted-by":"crossref","first-page":"19,719","DOI":"10.1016\/S0021-9258(17)32080-X","volume":"269","author":"P. Wollberg","year":"1994","unstructured":"Wollberg, P., Soderqvist, H., and Nelson, B. D. (1994) Mitogen activation of human peripheral T lymphocytes induces the formation of new cAMP response element-binding protein nuclear complexes.J. Biol. Chem. 269, 19,719\u201319,724.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR16","first-page":"4016","volume":"37","author":"P. M. Epstein","year":"1977","unstructured":"Epstein, P. M., Mills, J. S., Ross, C. P., Strada, S. J., Hersh, E. M., and Thompson, W. J. (1977) Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.Cancer Res. 37, 4016\u20134023.","journal-title":"Cancer Res."},{"key":"BF02737809_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-291X(79)91262-2","volume":"90","author":"D. J. Takemoto","year":"1979","unstructured":"Takemoto, D. J., Kaplan, S. A., and Appleman, M. M. (1979) Cyclic guanosine 3\u2032,5\u2032-monophosphate and phosphodiesterase activity in mitogen-stimulated human lymphocytes.Biochem. Biophys. Res. Commun. 90, 491\u2013497.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF02737809_CR18","first-page":"379","volume":"40","author":"P. M. Epstein","year":"1980","unstructured":"Epstein, P. M., Mills, J. S., Hersh, E. M., Strada, S. J., and Thompson, W. J. (1980) Activation of cyclic nucleotide phosphodiesterases from isolated human peripheral blood lymphocytes by mitogenic agents.Cancer Res. 40, 379\u2013386.","journal-title":"Cancer Res."},{"key":"BF02737809_CR19","first-page":"303","volume":"16","author":"P. M. Epstein","year":"1984","unstructured":"Epstein, P. M. and Hachisu, R. (1984) Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.Adv. Cyclic Nucleotide Protein Phosphorylation Res. 16, 303\u2013324.","journal-title":"Adv. Cyclic Nucleotide Protein Phosphorylation Res."},{"key":"BF02737809_CR20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0006-2952(91)90047-9","volume":"42","author":"S. A. Robicsek","year":"1991","unstructured":"Robicsek, S. A., Blanchard, D. K., Djeu, J. Y., Krzanowski, J. J., Szentivanyi, A., and Polson, J. B. (1991) Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.Biochem. Pharmacol. 42, 869\u2013877.","journal-title":"Biochem. Pharmacol."},{"key":"BF02737809_CR21","first-page":"1027","volume":"44","author":"P. Marcoz","year":"1993","unstructured":"Marcoz, P., Prigent, A. F., Lagarde, M., and Nemoz G. (1993) Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.Mol. Pharmacol. 44, 1027\u20131035.","journal-title":"Mol. Pharmacol."},{"key":"BF02737809_CR22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2222.1995.tb01109.x","volume":"25","author":"H. Tenor","year":"1995","unstructured":"Tenor, H., Staniciu, L., Schudt, C., Hatzelmann, A., Wendel, A., Djukanovic, R., Church, M. K., and Shute, J. K. (1995) Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes.Clin. Exp. Allergy 25, 616\u2013624.","journal-title":"Clin. Exp. Allergy"},{"key":"BF02737809_CR23","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1476-5381.1996.tb15629.x","volume":"118","author":"M. A. Giembycz","year":"1996","unstructured":"Giembycz, M. A., Corrigan, C. J., Seybold, J., Newton, R., and Barnes, P. J. (1996) Identification of cyclic AMP phosphodiesterases 3,4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2.Br. J. Pharmacol. 118, 1945\u20131958.","journal-title":"Br. J. Pharmacol."},{"key":"BF02737809_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/pulp.1996.0004","volume":"9","author":"K. H. Banner","year":"1996","unstructured":"Banner, K. H., Bertin, B., Moodley, I., and Page, C. P. (1996) Effect of isoenzyme selective phosphodiesterase inhibitors on the proliferation of murine thymus and spleen cells.Pulm. Pharmacol. 9, 35\u201341.","journal-title":"Pulm. Pharmacol."},{"key":"BF02737809_CR25","first-page":"399","volume":"46","author":"J. A. Beavo","year":"1994","unstructured":"Beavo, J. A., Conti, M., and Heaslip, R. J. (1994) Multiple cyclic nucleotide phosphodiesterases.Mol. Pharmacol. 46, 399\u2013405.","journal-title":"Mol. Pharmacol."},{"key":"BF02737809_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0163-7258(91)90039-O","volume":"51","author":"W. J. Thompson","year":"1991","unstructured":"Thompson, W. J. (1991) Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.Pharmacol. Ther. 51, 13\u201333.","journal-title":"Pharmacol. Ther."},{"key":"BF02737809_CR27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0898-6568(94)90018-3","volume":"6","author":"G. B. Bolger","year":"1994","unstructured":"Bolger, G. B. (1994) Molecular biology of the cyclic AMP-specific cyclic nucleotide phosphodiesterases: a diverse family of regulatory enzymes.Cell. Signal. 6, 851\u2013859.","journal-title":"Cell. Signal."},{"key":"BF02737809_CR28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1995.75.4.725","volume":"75","author":"J. A. Beavo","year":"1995","unstructured":"Beavo, J. A. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.Physiol. Rev. 75, 725\u2013748.","journal-title":"Physiol. Rev."},{"key":"BF02737809_CR29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/edrv-16-3-370","volume":"16","author":"M. Conti","year":"1995","unstructured":"Conti, M., Nemoz, G., Sette, C., and Vicini, E. (1995). Recent progress in understanding the hormonal regulation of phosphodiesterases.Endoc. Rev. 16, 370\u2013389.","journal-title":"Endoc. Rev."},{"key":"BF02737809_CR30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/bj2430533","volume":"243","author":"P. M. Epstein","year":"1987","unstructured":"Epstein, P. M., Moraski, S., Jr., and Hachisu, R. (1987) Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.Biochem. J. 243, 533\u2013539.","journal-title":"Biochem. J."},{"key":"BF02737809_CR31","doi-asserted-by":"crossref","first-page":"11,236","DOI":"10.1073\/pnas.93.20.11236","volume":"93","author":"X. Jiang","year":"1996","unstructured":"Jiang, X., Li, J., Paskind, M., and Epstein, P. M. (1996) Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.Proc. Natl. Acad. Sci. USA 93, 11,236\u201311,241.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02737809_CR32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.181.4103.952","volume":"181","author":"H. R. Bourne","year":"1973","unstructured":"Bourne, H. R., Tomkins, G. M., and Dion, S. (1973) Regulation of phosphodiesterase synthesis: requirement for cyclic adenosine monophosphate-dependent protein kinase.Science 181, 952\u2013954.","journal-title":"Science"},{"key":"BF02737809_CR33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0378-1119(93)90274-7","volume":"129","author":"R. Obernolte","year":"1993","unstructured":"Obernolte, R., Bhakta, S., Alvarez, R., Bach, C., Zuppan, P., Mulkins, M., Jarnagin, K., and Shelton, E. R. (1993) The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE-IV) reveals a multigene family.Gene 129, 239\u2013247.","journal-title":"Gene"},{"key":"BF02737809_CR34","first-page":"1195","volume":"263","author":"T. J. Torphy","year":"1992","unstructured":"Torphy, T. J., Zhou, H.-L., and Cieslinski, L. B. (1992) Stimulation of beta adrenoceptors in a human monocyte cell line (U937) upregulates cyclic AMP-specific phosphodiesterase activity.J. Pharmacol. Exp. Ther. 263, 1195\u20131205.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR35","first-page":"1164","volume":"47","author":"M. W. Verghese","year":"1995","unstructured":"Verghese, M. W., McConnell, R. T., Lenhard, J. M., Hamacher, L., and Jin, S.-L. C. (1995) Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.Mol. Pharmacol. 47, 1164\u20131171.","journal-title":"Mol. Pharmacol."},{"key":"BF02737809_CR36","first-page":"1955","volume":"40","author":"W. J. Thompson","year":"1980","unstructured":"Thompson, W. J., Ross, C. P., Strada, S. J., Hersh, E. M., and Lavis, V. R. (1980) Comparative analyses of cyclic adenosine 3\u2032:5\u2032-monophosphate phosphodiesterases of human peripheral blood monocytes and cultured P388D1 cells.Cancer Res. 40, 1955\u20131960.","journal-title":"Cancer Res."},{"key":"BF02737809_CR37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1073\/pnas.69.1.269","volume":"69","author":"V. Manganiello","year":"1972","unstructured":"Manganiello, V., and Vaughan, M. (1972) Prostaglandin E1 effects on adenosine 3\u2032:5\u2032-monophosphate concentration and phosphodiesterase activity in fibroblasts.Proc. Natl. Acad. Sci. USA 69, 269\u2013273.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02737809_CR38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1073\/pnas.69.2.459","volume":"69","author":"M. D'Armiento","year":"1972","unstructured":"D'Armiento, M., Johnson, G. S., and Pastan, I. (1972) Regulation of adenosine 3\u2032:5\u2032-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentrations of cyclic adenosine monophosphate.Proc. Natl. Acad. Sci. USA 69, 450\u2013462.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02737809_CR39","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1016\/S0021-9258(19)42033-4","volume":"249","author":"T. E. Russell","year":"1974","unstructured":"Russell, T. E. and Pastan, I. H. (1974) Cyclic adenosine 3\u2032:5\u2032-monophosphate and cyclic guanosine 3\u2032:5\u2032-monophosphate phosphodiesterase activities are under separate genetic control.J. Biol. Chem. 249, 7764\u20137769.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.180.4083.304","volume":"180","author":"P. Uzunov","year":"1972","unstructured":"Uzunov, P., Shein, H. M., and Weiss, B. (1972) Cyclic AMP phosphodiesterase in cloned astrocytoma cells: norepinephrine induces a specific enzyme form.Science 180, 304\u2013306.","journal-title":"Science"},{"key":"BF02737809_CR41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000136518","volume":"12","author":"E. T. Browning","year":"1974","unstructured":"Browning, E. T., Brostrom, C. O., and Groppi, V. E., Jr. (1974) Altered adenosine cyclic 3\u2032:5\u2032-monophosphate synthesis and degradation by C-6 astrocytoma cells following prolonged exposure to norepinephrine.Mol. Pharmacol. 12, 32\u201340.","journal-title":"Mol. Pharmacol."},{"key":"BF02737809_CR42","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1073\/pnas.71.10.3844","volume":"71","author":"J. P. Schwartz","year":"1974","unstructured":"Schwartz, J. P. and Passonneau, J. V. (1974) Cyclic AMP-mediated induction of the cyclic AMP phosphodiesterase in C6 glioma cells.Proc. Natl. Acad. Sci. USA 71, 3844\u20133848.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02737809_CR43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0304-4165(81)90239-7","volume":"657","author":"P. Onali","year":"1981","unstructured":"Onali, P., Schwartz, J. P., Hanbauer, I., and Costa, E. (1981) Regulation by \u03b2-adrenergic receptor of a Ca2+-independent adenosine 3\u2032,5\u2032-(cyclic) monophosphate phosphodiesterase in C6 glioma cells.Biochim. Biophys. Acta 657, 285\u2013292.","journal-title":"Biochim. Biophys. Acta"},{"key":"BF02737809_CR44","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0021-9258(17)40677-6","volume":"252","author":"P. S. Ross","year":"1977","unstructured":"Ross, P. S., Manganiello, V. C., and Vaughan, M. (1977) Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2-dibutyryl adenosine 3\u2032:5\u2032-monophosphate.J. Biol. Chem. 252, 1448\u20131452.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR45","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1016\/S0021-9258(17)37021-7","volume":"209","author":"T. Kovala","year":"1994","unstructured":"Kovala, T., Lorimer, I. A. J., Brickenden, A. M., Ball, E. H., and Sanwal, B. D. (1994) Protein kinase A regulation of cAMP phosphodiesterase expression in rat skeletal myoblasts.J. Biol. Chem. 209, 8680\u20138685.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1126\/science.178053","volume":"192","author":"K. P. Minneman","year":"1976","unstructured":"Minneman, K. P. and Iversen, L. L. (1976) Cholera toxin induces pineal enzymes in culture.Science 192, 803\u2013805.","journal-title":"Science"},{"key":"BF02737809_CR47","first-page":"552","volume":"11","author":"M. A. Oleshansky","year":"1975","unstructured":"Oleshansky, M. A. and Neff, N. H. (1975) Rat pineal adenosine cyclic 3\u2032,5\u2032-monophosphate phosphodiesterase activity: modulation in vivo by a beta adrenergic receptor.Mol. Pharmacol. 11, 552\u2013557.","journal-title":"Mol. Pharmacol."},{"key":"BF02737809_CR48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1210\/endo-110-4-1189","volume":"110","author":"M. Conti","year":"1982","unstructured":"Conti, M., Toscano, M. V., Petrelli, L., Geremia, R., and Stefanini, M. (1982) Regulation by follicle-stimulating hormone and dibutyryl adenosine 3\u2032,5\u2032-monophosphate of a phosphodiesterase isoenzyme of the Sertoli cell.Endocrinology 110, 1189\u20131196.","journal-title":"Endocrinology"},{"key":"BF02737809_CR49","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1210\/endo-114-6-2361","volume":"114","author":"M. Conti","year":"1984","unstructured":"Conti, M., Kasson, B. G., and Hsueh, A. J. W. (1984) Hormonal regulation of 3\u2032,5\u2032-adenosine monophosphate phosphodiesterases in cultured rat granulosa cells.Endocrinology 114, 2361\u20132368.","journal-title":"Endocrinology"},{"key":"BF02737809_CR50","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1073\/pnas.86.21.8197","volume":"86","author":"J. V. Swinnen","year":"1989","unstructured":"Swinnen, J. V., Joseph, D. R., and Conti, M. (1989) The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP.Proc. Natl. Acad. Sci. USA 86, 8197\u20138201.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BF02737809_CR51","doi-asserted-by":"crossref","first-page":"18,370","DOI":"10.1016\/S0021-9258(18)55280-7","volume":"266","author":"J. V. Swinnen","year":"1991","unstructured":"Swinnen, J. V., Tsikalas, K. E., and Conti, M. (1991) Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell.J. Biol. Chem. 266, 18,370\u201318,377.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR52","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/bi00025a003","volume":"34","author":"M. Conti","year":"1995","unstructured":"Conti, M., Iona, S., Cuomo, M., Swinnen, J. V., Odeh, J., and Svoboda, M. E. (1995) Characterization of a hormone-inducible, high affinity adenosine 3\u2032-5\u2032-cyclic monophosphate phosphodiesterase from the rat Sertoli cell.Biochemistry 34, 7979\u20137987.","journal-title":"Biochemistry"},{"key":"BF02737809_CR53","doi-asserted-by":"crossref","first-page":"23,598","DOI":"10.1074\/jbc.270.40.23598","volume":"270","author":"T. J. Torphy","year":"1995","unstructured":"Torphy, T. J., Zhou, H.-L., Foley, J. J., Sarau, H. M., Manning, C. D., and Barnette, M. S. (1995) Salbutamol up-regulates PDE-4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2.J. Biol. Chem. 270, 23,598\u201323,604.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-5793(96)00300-6","volume":"384","author":"G. Nemoz","year":"1996","unstructured":"Nemoz, G., Zhang, R. B., Sette, C., and Conti, M. (1996) Identification of cyclic AMP-phosphodiesterase variants from the PDE-4D gene expressed in human peripheral monouclear cells.FEBS Lett. 384, 97\u2013102.","journal-title":"FEBS Lett."},{"key":"BF02737809_CR55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-5793(94)00788-8","volume":"350","author":"P. Engels","year":"1994","unstructured":"Engels, P., Fichtel, K., and Lubbert, H. (1994) Expression and regulation of human and rat phosphodiesterase type IV isogenes.FEBS Lett. 350, 291\u2013295.","journal-title":"FEBS Lett."},{"key":"BF02737809_CR56","first-page":"1279","volume":"9","author":"G. Nemoz","year":"1995","unstructured":"Nemoz, G., Sette, C., Hess, M., Muca, C., Vallar, L., and Conti, M. (1995) Activation of cyclic nucleotide phosphodiesterases in FRTL-5 thyroid cells expressing a constitutively active Gs\u03b1.Mol. Endocrinol. 9, 1279\u20131287.","journal-title":"Mol. Endocrinol."},{"key":"BF02737809_CR57","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1042\/bj3100975","volume":"310","author":"S. Spence","year":"1995","unstructured":"Spence, S., Rena, G., Sweeney, G., and Houslay, M. D. (1995) Induction of Ca2+\/calmodulin-stimulated cyclic AMP phosphodiesterase (PDE-1) activity in Chinese hamster ovary cells (CHO) by phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase C isoforms.Biochem. J. 310, 975\u2013982.","journal-title":"Biochem. J."},{"key":"BF02737809_CR58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/bj3210157","volume":"321","author":"S. Spence","year":"1997","unstructured":"Spence, S., Rena, G., Sullivan, M., Erdogan, S., and Houslay, M. D. (1997) Receptor-mediated stimulation of lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE-1B isoform of Ca2+\/calmodulin-stimulated cAMP phosphodiesterase.Biochem. J. 321, 157\u2013163.","journal-title":"Biochem. J."},{"key":"BF02737809_CR59","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1098\/rstb.1996.0017","volume":"351","author":"E. Lalli","year":"1996","unstructured":"Lalli, E., Lee, J. S., Lamas, M., Tamai, K., Zazopoulos, E., Nantel, F., Penna, L., Foulkes, N. S., and Sassone-Corsi, P. (1996) The nuclear response to cAMP: role of transcription factor CREM.Phil. Trans. R. Soc. Lond. B 351, 201\u2013209.","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BF02737809_CR60","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.1016\/S0021-9258(17)37100-4","volume":"25","author":"C. Sette","year":"1994","unstructured":"Sette, C., Iona, S., and Conti, M. (1994) The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.J. Biol. Chem. 25, 9245\u20139252.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR61","doi-asserted-by":"crossref","first-page":"18,271","DOI":"10.1016\/S0021-9258(17)32297-4","volume":"269","author":"C. Sette","year":"1994","unstructured":"Sette, C., Vicini, E., and Conti, M. (1994) The ratPDE-3\/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase.J. Biol. Chem. 269, 18,271\u201318,274.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR62","doi-asserted-by":"crossref","first-page":"16,526","DOI":"10.1074\/jbc.271.28.16526","volume":"271","author":"C. Sette","year":"1996","unstructured":"Sette, C. and Conti, M. (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase.J. Biol. Chem. 271, 16,526\u201316,534.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR63","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0006-291X(90)91973-V","volume":"169","author":"L. Valette","year":"1990","unstructured":"Valette, L., Prigent, A. F., Nemoz, G., Anker, G., Macovschi, O., and Lagarde, M. (1990) Concanavalin A stimulates the rolipram-sensitive isoforms of cyclic nucleotide phosphodiesterase in rat thymic lymphocytes.Biochem. Biophys. Res. Commun. 169, 864\u2013872.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF02737809_CR64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0167-4889(93)90187-T","volume":"1176","author":"P. Marcoz","year":"1993","unstructured":"Marcoz, P., Nemoz, G., Prigent, A.-F., and Lagarde, M. (1993) Phosphatidic acid stimulates the rolipram-sensitive cyclic nucleotide phosphodiesterase from rat thymocytes.Biochim. Biophys. Acta. 1176, 129\u2013136.","journal-title":"Biochim. Biophys. Acta."},{"key":"BF02737809_CR65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0898-6568(95)02032-2","volume":"8","author":"A. M. Michie","year":"1996","unstructured":"Michie, A. M., Lobban, M., Muller, T., Harnett, M. M., and Houslay, M. D. (1996) Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.Cell. Signal. 8, 97\u2013110.","journal-title":"Cell. Signal."},{"key":"BF02737809_CR66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcp.1041500119","volume":"150","author":"N. Meskini","year":"1992","unstructured":"Meskini, N., Hosni, M., Nemoz, G., Lagarde M., and Prigent, A.-F. (1992) Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells.J. Cell. Physol. 150, 140\u2013148.","journal-title":"J. Cell. Physol."},{"key":"BF02737809_CR67","first-page":"150","volume":"43","author":"R. G. Coffey","year":"1983","unstructured":"Coffey, R. G. and Hadden, J. W. (1983) Phorbol myristate acetate stimulation of lymphocyte guanylate cyclase and cyclic guanosine 3\u2032\u22365\u2032-monophosphate phosphodiesterase and reduction of adenylate cyclase.Cancer Res. 43, 150\u2013158.","journal-title":"Cancer Res."},{"key":"BF02737809_CR68","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1016\/S0021-9258(17)33203-9","volume":"251","author":"W. J. Thompson","year":"1976","unstructured":"Thompson, W. J., Ross, C. P., Pledger, W. J., Hersch, E. M., Banner, R. L., and Strada, S. J. (1976) Cyclic adenosine 3\u2032\u22365\u2032-monophosphate phosphodiesterase: distinct forms in human lymphocytes and monocytes.J. Biol. Chem. 251, 4922\u20134929.","journal-title":"J. Biol. Chem."},{"key":"BF02737809_CR69","first-page":"810","volume":"276","author":"C. D. Manning","year":"1996","unstructured":"Manning, C. D., McLaughlin, M. M., Livi, G. P., Cieslinski, L. B., Torphy, T. J., and Barnette, M. S. (1996) Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterase 4A and 4B.J. Pharmacol. Exp. Ther. 276, 810\u2013818.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1042\/bj3210165","volume":"321","author":"S. Erdogan","year":"1997","unstructured":"Erdogan, S. and Houslay, M. D. (1997) Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by upregulating PDE-3 and inducing PDE-4D1 and PDE-4D2 splice variants as well as down-regulating a novel PDE-4A splice variant.Biochem. J. 321, 165\u2013175.","journal-title":"Biochem. J."},{"key":"BF02737809_CR71","first-page":"25","volume":"6","author":"W. J. Thompson","year":"1980","unstructured":"Thompson, W. J., Ross, C. P., Hersh, E. M., Epstein, P. M., and Strada, S. J. (1980) Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.J. Cyclic Nucleotide Res. 6, 25\u201336.","journal-title":"J. Cyclic Nucleotide Res."},{"key":"BF02737809_CR72","first-page":"9","volume":"46","author":"D. Raeburn","year":"1993","unstructured":"Raeburn, D., Souness, J. E., Tomkinson, A., and Karlsson, J.-A. (1993) Isozyme-selective cyclic nucleotide phosphodiesterase inhibitors: biochemistry, pharmacology and therapeutic potential in asthma.Prog. Drug. Res. 46, 9\u201332.","journal-title":"Prog. Drug. Res."},{"key":"BF02737809_CR73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0192-0561(93)90052-Z","volume":"15","author":"J. Semmler","year":"1993","unstructured":"Semmler, J., Wachtel, H., and Endres, S. (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-\u03b1 production by human mononuclear cells.Int. J. Immunopharmacol. 15, 409\u2013413.","journal-title":"Int. J. Immunopharmacol."},{"key":"BF02737809_CR74","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.4049\/jimmunol.155.10.4909","volume":"155","author":"T. Kambayashi","year":"1995","unstructured":"Kambayashi, T., Jacob, C. O., Zhou, D., Mazurek, N., Fong, M., and Strassmann, G. (1995) Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-\u03b1 and IL-6 release by endotoxin-stimulated macrophages.J. Immunol. 155, 4909\u20134916.","journal-title":"J. Immunol."},{"key":"BF02737809_CR75","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF01797868","volume":"44","author":"J. V. Wauwe","year":"1995","unstructured":"Wauwe, J. V., Aerts, F., Walter, H., and de Boer, M. (1995) Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors.Inflamm. Res. 44, 400\u2013405.","journal-title":"Inflamm. Res."},{"key":"BF02737809_CR76","first-page":"1313","volume":"272","author":"M. W. Verghese","year":"1995","unstructured":"Verghese, M. W., McConnell, R. T., Strickland, A. B., Gooding, R. C., Stimpson, S. A., Yarnall, D. P., Taylor, J. D., and Furdon, P. J. (1995) Differential regulation of human monocyte-derived TNF\u03b1 and IL-1\u03b2 by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.J. Pharmacol. Exp. Ther. 272, 1313\u20131320.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2249.1995.tb03613.x","volume":"100","author":"L. Sekut","year":"1995","unstructured":"Sekut, L., Yarnall, D., Stimpson, S. A., Noel, L. S., Bateman-Fite, R., Clark, R. L., Brackeen, M. F., Menius, J. A., Jr., and Connolly, K. M. (1995) Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.Clin. Exp. Immunol. 100, 126\u2013132.","journal-title":"Clin. Exp. Immunol."},{"key":"BF02737809_CR78","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1183\/09031936.95.08071179","volume":"8","author":"C. Schudt","year":"1995","unstructured":"Schudt, C., Tenor, H., and Hatzelmann, A. (1995) PDE isoenzymes as targets for anti-asthma drugs.Eur. Respir. J. 8, 1179\u20131183.","journal-title":"Eur. Respir. J."},{"key":"BF02737809_CR79","first-page":"1484","volume":"278","author":"L. Foissier","year":"1996","unstructured":"Foissier, L., Lonchampt, M., Coge, F., and Canet, E. (1996)In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.J. Pharmacol. Exp. Ther. 278, 1484\u20131490.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR80","first-page":"1349","volume":"278","author":"C. R. Turner","year":"1996","unstructured":"Turner, C. R., Cohan V. L., Cheng, J. B., Showell, H. J., Pazoles, C. J., and Watson, J. W. (1996) Thein vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.J. Pharmacol. Exp. Ther. 278, 1349\u20131355.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR81","first-page":"1356","volume":"278","author":"V. L. Cohan","year":"1996","unstructured":"Cohan, V. L., Showell, H. J., Fisher, D. A., Pazoles, C. J., Watson, J. W., Turner, C. R., and Cheng, J. B. (1996)In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.J. Pharmacol. Exp. Ther. 278, 1356\u20131361.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0165-6147(96)10039-0","volume":"17","author":"M. A. Giembycz","year":"1996","unstructured":"Giembycz, M. A. (1996) Phosphodiesterase 4 and tolerance to \u03b22 agonists in asthma.Trends Pharmacol. Sci. 17, 0 331\u2013336.","journal-title":"Trends Pharmacol. Sci."},{"key":"BF02737809_CR83","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3565(24)36389-X","volume":"280","author":"F. Gantner","year":"1997","unstructured":"Gantner, F., Kusters, S., Wendel, A., Hatzelmann, A., Schudt, C., and Tiegs, G. (1997) Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors.J. Pharmacol. Exp. Ther. 280, 53\u201360.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR84","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.bjp.0701124","volume":"121","author":"F. Gantner","year":"1997","unstructured":"Gantner, F., Kupferschmidt R., Schudt, C., Wendel, A., and Hatzelmann, A. (1997)In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-\u03b1 release by PDE inhibitors.Br. J. Pharmacol. 121, 221\u2013231.","journal-title":"Br. J. Pharmacol."},{"key":"BF02737809_CR85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(96)00947-8","volume":"321","author":"B. Siegmund","year":"1997","unstructured":"Siegmund, B., Eigler, A., Moeller, J., Greten, T. F., Hartmann, G., and Endres, S. (1997) Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents.Eur. J. Pharmacol. 321, 231\u2013239.","journal-title":"Eur. J. Pharmacol."},{"key":"BF02737809_CR86","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-3565(24)36487-0","volume":"280","author":"J. B. Cheng","year":"1997","unstructured":"Cheng, J. B., Watson, J. W., Pazoles, C. J., Eskra, J. D., Griffiths, R. J., Cohan, V. L., Turner, C. R., Showell, H. J., and Pettipher, E. R. (1997) The phosphodiesterase type 4 (PDE-4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNF\u03b1) production in mice: effect of adrenalectomy.J. Pharmacol. Exp. Ther. 280, 621\u2013626.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF02737809_CR87","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s001090050094","volume":"75","author":"H. Dinter","year":"1997","unstructured":"Dinter H., Onuffer, J., Faulds, D., and Perez, H. D. (1997) Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis.J. Mol. Med. 75, 95\u2013102.","journal-title":"J. Mol. Med."},{"key":"BF02737809_CR88","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/00002030-199510000-00004","volume":"9","author":"J. B. Angel","year":"1995","unstructured":"Angel, J. B., Saget, B. M., Walsh, S. P., Greten, T. F., Dinarello, C. A., Skolnik, P. R., and Endres, S. (1995) Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.AIDS 9, 1137\u20131144.","journal-title":"AIDS"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02737809.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02737809\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02737809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:10:38Z","timestamp":1737504638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02737809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":88,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["BF02737809"],"URL":"https:\/\/doi.org\/10.1007\/bf02737809","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}